Carla Rodriguez-Watson, PhD, MPH, is the Scientific Director of the Innovation in Medical Evidence Development and Surveillance (IMEDS) program at the Reagan-Udall Foundation for the FDA.
Dr. Rodriguez-Watson is an infectious disease epidemiologist with particular research focus in public health surveillance, clinical epidemiology of viral hepatitis and HIV, influenza, substance abuse, liver and kidney disease, and the use of real-world evidence in health services research. Methodological areas of focus include comparative effectiveness, multi-level modeling, predictive modeling, and test accuracy.
Dr. Rodriguez-Watson has worked in academia, government, and the pharmaceutical industry as well as local and global nonprofits. Most recently, she was a Research Scientist II at Kaiser Permanente, Mid-Atlantic States. Prior posts include serving as a Biostatistician at the Center for AIDS Research at the University of Washington and spending more than a decade as a public health researcher at the NYC Department of Health and Mental Hygiene, the San Francisco Department of Public Health, and Seattle-King County Public Health. She is also associate faculty in the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health.
Dr. Rodriguez-Watson earned her PhD in Epidemiology from the University of Washington School of Public Health, her MPH from Columbia University Mailman School of Public Health, and her BA from Rutgers University.